Carl Borrebaeck brings experience from his time as a board member of Immunovia AB, SenzaGen AB, CB Ocean Capital AB, Alligator Bioscience AB, Clinical Laserthermia Systems AB, Scandion A/S, and commercial experience from a number of IPOs.
He has a DSc in biochemistry with a focus on molecular immunology, is a professor and former Vice President at Lund University and has contributed to the start of several new life science companies. He received AkzoNobel’s Science Prize in 2009, the Royal Academy of Engineering Science’s gold medal for ground-breaking cancer biomarker research in 2012, Research!Sweden Prize for medical research in 2012 and the Biotech Builder award in 2017 for outstanding entrepreneurial achievements.
“Qlucore has an exciting untapped commercial potential which I look forward to trying to develop, utilizing the experience from both research and all my other ventures,” comments Carl Borrebaeck.
